Cargando…
Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic
IMPORTANCE: The coronavirus disease 2019 (COVID-19) pandemic has required a shift in health care delivery platforms, necessitating a new reliance on telemedicine. OBJECTIVE: To evaluate whether inequities are present in telemedicine use and video visit use for telemedicine visits during the COVID-19...
Autores principales: | Eberly, Lauren A., Kallan, Michael J., Julien, Howard M., Haynes, Norrisa, Khatana, Sameed Ahmed M., Nathan, Ashwin S., Snider, Christopher, Chokshi, Neel P., Eneanya, Nwamaka D., Takvorian, Samuel U., Anastos-Wallen, Rebecca, Chaiyachati, Krisda, Ambrose, Marietta, O’Quinn, Rupal, Seigerman, Matthew, Goldberg, Lee R., Leri, Damien, Choi, Katherine, Gitelman, Yevginiy, Kolansky, Daniel M., Cappola, Thomas P., Ferrari, Victor A., Hanson, C. William, Deleener, Mary Elizabeth, Adusumalli, Srinath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772717/ https://www.ncbi.nlm.nih.gov/pubmed/33372974 http://dx.doi.org/10.1001/jamanetworkopen.2020.31640 |
Ejemplares similares
-
Referral Rates for Cardiac Rehabilitation Among Eligible Inpatients After Implementation of a Default Opt-Out Decision Pathway in the Electronic Medical Record
por: Adusumalli, Srinath, et al.
Publicado: (2021) -
Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
por: Eberly, Lauren A., et al.
Publicado: (2021) -
Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
por: Eberly, Lauren A., et al.
Publicado: (2021) -
Predictors of telemedicine use during the COVID-19 pandemic in the United States–an analysis of a national electronic medical record database
por: Khatana, Sameed Ahmed M., et al.
Publicado: (2022) -
Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease
por: Dayoub, Elias J., et al.
Publicado: (2021)